NM_012249.4:c.563A>T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_012249.4(RHOQ):c.563A>T(p.His188Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000182 in 1,591,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H188Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_012249.4 missense
Scores
Clinical Significance
Conservation
Publications
- onychodystrophy, osteodystrophy, impaired intellectual development, and seizures syndromeInheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHOQ | ENST00000238738.9 | c.563A>T | p.His188Leu | missense_variant | Exon 5 of 5 | 1 | NM_012249.4 | ENSP00000238738.4 | ||
PIGF | ENST00000281382.11 | c.*450T>A | 3_prime_UTR_variant | Exon 6 of 6 | 1 | NM_002643.4 | ENSP00000281382.6 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152218Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000306 AC: 7AN: 229088 AF XY: 0.0000322 show subpopulations
GnomAD4 exome AF: 0.0000132 AC: 19AN: 1438804Hom.: 0 Cov.: 28 AF XY: 0.0000126 AC XY: 9AN XY: 715720 show subpopulations
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74490 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.563A>T (p.H188L) alteration is located in exon 5 (coding exon 5) of the RHOQ gene. This alteration results from a A to T substitution at nucleotide position 563, causing the histidine (H) at amino acid position 188 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at